Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
07/2012
07/19/2012WO2012095516A1 Human antibodies cross-reacting with a bacterial and a self antigen from atherosclerotic plaques
07/19/2012WO2012095432A2 Tlr3 binding agents
07/19/2012WO2012095412A1 Combination therapy including tumor associated antigen binding antibodies
07/19/2012WO2012064792A3 Protein complexes for antigen binding and methods of use
07/19/2012WO2012064760A3 Materials and methods for directing an immune response to an epitope
07/19/2012WO2012064627A3 Subcutaneously administered anti-il-6 receptor antibody
07/19/2012WO2012059857A3 Pan-her antibody composition
07/19/2012WO2012036870A3 Monoclonal antibodies and detection methods for enzymes that confer resistance to 2,4-dichlorophenoxyacetic acid
07/19/2012WO2012031260A3 Staphylococcus aureus specific human recombinant polyclonal antibodies and uses thereof
07/19/2012WO2012027570A4 Dual variable domain immunoglobulins and uses thereof
07/19/2012WO2012021786A3 Anti-hemagglutinin antibody compositions and methods of use thereof
07/19/2012WO2012019061A3 Novel effectors and methods of use
07/19/2012WO2012004631A3 Recombinant antibody structures binding to and blocking the activity of vascular endothelial growth factor 2 (vegfr- 2 /kdr)
07/19/2012WO2011160078A3 Use of camelid-derived variable heavy chain variable regions targeting cd18 and icam-1 as a microbicide to prevent hiv-1 transmission
07/19/2012WO2011131178A4 Method for detecting a salmonella infection
07/19/2012WO2011130434A9 Antibodies that bind human cd27 and uses thereof
07/19/2012US20120184719 Hybridoma producing anti-methylated dna antibody and utilization of same
07/19/2012US20120184718 Bispecific death receptor agonistic antibodies
07/19/2012US20120184717 Antibodies against extended type 1 chain antigens, derivatives thereof and use
07/19/2012US20120184716 Methods for the Generation of Multispecific and Multivalent Antibodies
07/19/2012US20120184459 Taste Receptors Of The T1R Family From Domestic Cat
07/19/2012US20120184016 Novel protein and gene that codes therefor
07/19/2012US20120183964 Mammalian cytokine; related reagents
07/19/2012US20120183599 Pharmaceutical Composition
07/19/2012US20120183566 Aldehyde-Tagged Immunoglobulin Polypeptides and Methods of Use Thereof
07/19/2012US20120183565 Fully human antibodies to btla
07/19/2012US20120183562 Secreted fxyd proteins expressed in response to epithelial tissue damage, and uses therefor
07/19/2012US20120183561 Alpha-4-beta-7 heterodimer specific antagonist antibody
07/19/2012US20120183560 Monoclonal Antibodies
07/19/2012US20120183559 Novel anti-igf-ir antibodies and uses thereof
07/19/2012US20120183558 Antibody molecules which bind il-17a and il-17f
07/19/2012US20120183554 Biomarker
07/19/2012US20120183553 Treatment and diagnosis of immune disorders
07/19/2012US20120183552 Kidney disease targets and uses thereof
07/19/2012US20120183551 Novel human p53 splice variant displaying differential transcriptional activity
07/19/2012US20120183550 Therapeutic Using a Bispecific Antibody
07/19/2012US20120183549 Chemokine receptor binding polypeptides
07/19/2012US20120183545 CD20-Binding Polypeptide Compositions and Methods
07/19/2012US20120183544 Diagnosis and treatment of neuroectodermal tumors
07/19/2012US20120183542 Treating neurological disorders
07/19/2012US20120183539 Cancer Metastasis Inhibitor
07/19/2012US20120183533 Mimotopes of hiv env
07/19/2012US20120183473 Active ingredient and method for testing an active ingredient
07/19/2012US20120183472 Immunotherapy of b-cell malignancies using anti-cd22 antibodies
07/19/2012US20120183471 Specific binding proteins and uses thereof
07/19/2012CA2824805A1 Il-27 antagonists for treating inflammatory diseases
07/19/2012CA2824752A1 Bcl-2-like protein 11 srm/mrm assay
07/19/2012CA2824389A1 Antibodies directed against influenza
07/19/2012CA2824313A1 Tlr3 binding agents
07/19/2012CA2824143A1 Aldehyde-tagged immunoglobulin polypeptides and method of use thereof
07/19/2012CA2824060A1 Anti-tlr4 antibodies and methods of use thereof
07/19/2012CA2823913A1 Stem cell factor inhibitor
07/19/2012CA2823812A1 Antibody molecules which bind il-17a and il-17f
07/19/2012CA2821117A1 Combination therapy including tumor associated antigen binding antibodies
07/18/2012EP2476754A1 Methods for the identification and repair of amino acid residues destabilizing single-chain variable fragments (scFv)
07/18/2012EP2476707A1 Self-cleaving ribozymes and uses thereof
07/18/2012EP2476706A2 Anti-MN antibodies and methods of using same
07/18/2012EP2476705A1 Monoclonal antibodies against NKG2A
07/18/2012EP2476704A2 Humanized monoclonal antibodies to heptocyte growth factor
07/18/2012EP2476703A1 Human antibodies cross-reacting with a bacterial and a self antigen from atherosclerotic plaques
07/18/2012EP2476702A1 Monoclonal antibodies against the pbp2-a protein and homologous sequences for the treatment of infections by and immunodiagnostics of bacteria of the firmicutes phylum
07/18/2012EP2476438A1 Medicament including antibody composition specifically bound to human cc chemokine receptor 4 (ccr4)
07/18/2012EP2476427A2 A method of treating cancer comprising a VEGF-B antagonist
07/18/2012EP2475685A1 An isolated monophosphorylated peptide derived from human alpha-enolase useful for diagnosis and treatment of pancreatic adenocarcinoma, antibodies directed against the said monophosphorylated peptide, and uses thereof
07/18/2012EP2475684A1 High affinity human antibodies to human protease-activated receptor-2
07/18/2012EP2475683A1 Antibodies against glucagon receptor and their use
07/18/2012EP2475682A1 Multivalent antibodies
07/18/2012EP2475387A1 Use of vap-1 inhibitors for treating fibrotic conditions
07/18/2012EP2475386A1 Hypoallergenic hybrid polypeptides for the treatment of allergy
07/18/2012EP2399993A9 Hypo-immunogenic streptavidin and use thereof
07/18/2012EP2231706B3 Biokinetics of fast-clearing polypeptides
07/18/2012EP1963368B1 Anti-il-17 antibodies
07/18/2012EP1893649B1 Method for the potentiation of opioid analgesics effects on pain
07/18/2012EP1871416B1 Methods for treating osteoarthitis pain by administering a nerve growth factor antagonist and compositions containing the same
07/18/2012EP1869086B1 Methods and compositions for modulating and detecting wisp activity
07/18/2012EP1711528B1 Treatment of cancer with novel anti-il 13 monoclonal antibodies
07/18/2012EP1432735B1 Antagonistic anti-htnfsf13b human antibodies
07/18/2012EP0906577B2 Screening compounds for the ability to alter the production of amyloid-beta peptide
07/18/2012CN1973205B Kit for diagnosing lawsonia intracellularis
07/18/2012CN1946734B Compositions and methods for the systemic treatment of arthritis
07/18/2012CN1935260B Human antibodies that bind human tnfalpha
07/18/2012CN1449445B Ev-vegf nucleic acids and polypeptides and methods of use
07/18/2012CN102597772A 5.9 kDa peptide immunoassay method
07/18/2012CN102597234A Humanized anti-amyloid-beta oligomer antibody
07/18/2012CN102597233A Humanized anti-amyloid-beta oligomer antibody
07/18/2012CN102597005A Bispecific antibodies that bind to complement proteins
07/18/2012CN102597004A Chimeric antibodies specific for CD151 and use thereof in the treatment of cancer
07/18/2012CN102597003A Compositions and methods for treating inflammatory disorders
07/18/2012CN102597002A Antibodies to ion channels
07/18/2012CN102597001A Antibodies for the detection of integrin complexes in FFPE material
07/18/2012CN102597000A Glycosylated repeat-motif-molecule conjugates
07/18/2012CN102596999A Antibody recognizing turn structure in amyloid beta
07/18/2012CN102596998A Treatment of vasculoproliferative conditions
07/18/2012CN102596997A Antibodies that specifically bind to A beta oligomers and use thereof
07/18/2012CN102596996A Antibody having activity of inhibiting infection with hepatitis c virus (hcv) and use of same
07/18/2012CN102596995A Method for the production of a glycosylated immunoglobulin
07/18/2012CN102596994A Variant immunoglobulins with improved manufacturability
07/18/2012CN102596260A Zirconium-radiolabeled, cysteine engineered antibody conjugates
07/18/2012CN102596245A Combination therapy of an afucosylated CD20 antibody with bendamustine
07/18/2012CN102590515A Clostridium difficile exotoxin A test kit and monoclonal antibodies therein
1 ... 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 ... 1494